The cardiovascular device segment is highly competitive and has reached market saturation because many companies produce similar products and there is limited room for innovation. These factors, however, meant low growth rates of prominent devices, such as cardiac pacemakers, over the past five years. Therefore, innovations in niche sectors, such as atrial fibrillation and ventricular assist devices, are poised for stronger growth in the near future.
This industry manufactures medical devices that use electric pulses to regulate a person's heartbeat.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.